Trial intelligence / Profile preview

EASY-MI Pilot Study

NCT00440778Phase 4Completed

Sponsor
Université Laval
Start
Feb 2007
Primary completion
Oct 2008
Modality
Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
Countries
1
01

Overview

A Phase 4 trial of abciximab in myocardial infarction (MI), sponsored by Université Laval. Started Feb 2007; status: completed.

02

Drugs

abciximab
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on NCT00440778.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00440778.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call